Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02078375 · ClinicalTrials.gov registry record · NA
The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis
A NA study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT02078375: Clinical Trial NA study, sponsored by Johns Hopkins University.
NCT02078375 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02078375, a NA study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
This study will evaluate if the combination of resistance exercise and protein supplementation will increase muscle strength and muscle mass among older individuals with rheumatoid arthritis (RA).
Interventions
- DIETARY_SUPPLEMENT Protein
- OTHER Resistance Exercise Program
- DIETARY_SUPPLEMENT Carbohydrate (Placebo)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2014-02 |
| Est. Completion | 2018-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02078375
The ClinicalTrials.gov registry entry for NCT02078375 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Protein is the first listed.
NCT02078375 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02078375 about?
NCT02078375 is a clinical study titled "The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis". This study will evaluate if the combination of resistance exercise and protein supplementation will increase muscle strength and muscle mass among older individuals with rheumatoid arthritis (RA).
What is the current status of trial NCT02078375?
This trial is currently terminated. It is a NA study. The enrollment target is 23 participants. The study started on 2014-02. Estimated completion is 2018-07-01.
What interventions are being tested in trial NCT02078375?
The interventions under investigation include: Protein (DIETARY_SUPPLEMENT), Resistance Exercise Program (OTHER), Carbohydrate (Placebo) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02078375?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.